Moderna says shipped 100 million COVID-19 vaccine doses to United States
Reuters
Published Mar 29, 2021 09:02AM ET
(Reuters) - Moderna (NASDAQ:MRNA) Inc said on Monday it has shipped 100 million doses of its COVID-19 vaccine to the United States, of which 88 million have been delivered to date in the first quarter of 2021.
The company expects to meet its promise of delivering the second batch of 100 million doses by the end of May and the third batch by the end of July, by delivering 40-50 million doses per month.
The U.S. government has this week hit the accelerator on its shipments of COVID-19 vaccines after a month of largely stagnant weekly deliveries, giving states the doses they need to finish vaccinating priority groups and open shots to all adults.
Moderna, which delivered 16 million doses in the fourth quarter of 2020, said its COVID-19 vaccine shipments has increased five-fold since its shot was granted an emergency authorization in December.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.